GFG Capital’s Cano Health, Inc. CANO Stock Holding History

GFG Capital’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-177	Closed	-$158K	–	170
2021 Q4	$158K	Hold	177	–	–	0.05%	143
2021 Q3	$225K	Buy	+177	New	+$214K	0.07%	111

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

GFG Capital's CANO Position: Q1 2022 in Review

GFG Capital sold out of Cano Health, Inc. (CANO) in Q1 2022, closing a stake of 177 shares — an estimated $158K sold.

GFG Capital first reported a position in CANO in Q3 2021 and held it in 2 quarters. The position peaked at $225K in Q3 2021. 146 funds tracked by Wall St. Rank hold CANO as of Q1 2022.

GFG Capital reported no remaining Cano Health, Inc. position as of Q1 2022 after selling out during the quarter.
GFG Capital sold 177 Cano Health, Inc. shares in Q1 2022, an estimated $158K.
GFG Capital first reported a position in Cano Health, Inc. in Q3 2021 and held it in 2 quarters.
GFG Capital's Cano Health, Inc. position peaked at $225K in Q3 2021.
146 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2022.

Based on GFG Capital's 13F filing for Q1 2022, filed 27 Apr 2022.